focus -WSS

focus

author：focus 2025-09-30 15:16:00 - browse：72

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Be careful with at

focus

WSS

Health AI: on the border between health care and tech

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Study on Amgen’s bispecific immunotherapy produces positive data

Hospitals are dialing back on venture capital investing

Study on Amgen’s bispecific immunotherapy produces positive data

Is there really a nursing shortage in the U.S.?

entertainment

focus

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Roche drug slashes death risk in early

At least 13 dead in Texas as scorching temps continue

Health tech investors get more selective as pandemic boom fades

Novavax promises a turnaround & Lilly roils the obesity market

STAT Summit: Meghan O’Rourke on making chronic illness visible

United colonoscopy coverage change 'may cost lives,' doctors say

Illinois Supreme Court finds assault weapons ban constitutional

Hepatitis C has a cure — but many Americans still lack access to it

How AI can help patients find reliable information about doctors

leisure time

J&J lung cancer data amount to new salvo against AstraZeneca

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Cassava Sciences’ Alzheimer’s clinical trials should be halted

After Optum profits sink, UnitedHealth makes changes

leisure time

knowledge

focus

hotspot